180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
180 Life Sciences Corp. (ATNF)
Company Research
Source: GlobeNewswire
PALO ALTO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (“180” or the “Company”) is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effective September 30, 2024. Mr. Jimenez, already a director of the Company, will play a key role in driving the financial strategy of the Company as it continues to grow and innovate in the pharma and biotechnology sectors. "We are excited to have Omar stepping onto our executive team," said Mr. Blair Jordan, CEO of 180. "His extensive financial expertise, combined with his forward-thinking approach, makes him the ideal CFO to guide us through this exciting chapter of growth and transformation for the Company." Mr. Jimenez has significant experience in the finance and operations sector, having worked in various high-profile roles in companies such as Golden Matrix Group Inc., Alfadan, Inc., Monaker Group, Inc., Marmel International, Inc., American Leisure Holdings, Inc., US Installation G
Show less
Read more
Impact Snapshot
Event Time:
ATNF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATNF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATNF alerts
High impacting 180 Life Sciences Corp. news events
Weekly update
A roundup of the hottest topics
ATNF
News
- 180 Life Sciences Corp. (NASDAQ: ATNF) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.MarketBeat
- 180 Life Sciences Corp. (NASDAQ: ATNF) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.MarketBeat
- 180 Life Sciences Corp. (NASDAQ: ATNF) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.MarketBeat
- 180 Life Sciences announces pricing of $2.9M registered direct offering [Seeking Alpha]Seeking Alpha
- 180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ RulesAccesswire
ATNF
Sec Filings
- 2/14/25 - Form SCHEDULE
- 2/13/25 - Form SCHEDULE
- 2/10/25 - Form 424B3
- ATNF's page on the SEC website